Dysregulation of CXCR3 signaling due to CXCL10 deficiency impairs the antiviral response to herpes simplex virus 1 infection

Journal of Immunology

Volumn 181, Issue 11, 2009, Pages 7985-7993

  Wuest, Todd R ^a   Carr, Daniel J J ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON INDUCIBLE PROTEIN 10;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; INFECTION CONTROL; KERATITIS; KNOCKOUT MOUSE; LEUKOCYTE; MALE; MOUSE; MOUSE MUTANT; NATURAL KILLER CELL; NERVOUS SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; VIRUS IMMUNITY; VIRUS REPLICATION; VIRUS TITRATION; WILD TYPE;

EID: 71849092343     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.11.7985     Document Type: Article

References (68)

1. Kennedy, P. G. 2005. Viral encephalitis. J. Neurol. 252: 268-272.
2. Kennedy, P. G., and A. Chaudhuri. 2002. Herpes simplex encephalitis. J. Neurol. Neurosurg. Psychiatry 73: 237-238.
3. Maghazachi, A. A., B. S. Skalhegg, B. Rolstad, and A. Al-Aoukaty. 1997. Interferon- inducible protein-10 and lymphotactin induce the chemotaxis and mobilization of intracellular calcium in natural killer cells through pertussis toxin-sensitive and -insensitive heterotrimeric G-proteins. FASEB J. 11: 765-774.
4. Ghiasi, H., S. Cai, G. C. Perng, A. B. Nesburn, and S. L. Wechsler. 2000. The role of natural killer cells in protection of mice against death and corneal scarring following ocular HSV-1 infection. Antiviral Res. 45: 33-45. (Pubitemid 30074191)
5. Reading, P. C., P. G. Whitney, D. P. Barr, M. J. Smyth, and A. G. Brooks. 2006. NK cells contribute to the early clearance of HSV-1 from the lung but cannot control replication in the central nervous system following intranasal infection. Eur. J. Immunol. 36: 897-905.
6. Kassim, S. H., N. K. Rajasagi, X. Zhao, R. Chervenak, and S. R. Jennings. 2006. In vivo ablation of CD11c-positive dendritic cells increases susceptibility to herpes simplex virus type 1 infection and diminishes NK and T-cell responses. J. Virol. 80: 3985-3993.
7. Mossman, K. L., and A. A. Ashkar. 2005. Herpesviruses and the innate immune response. Viral Immunol. 18: 267-281.
8. Manickan, E., and B. T. Rouse. 1995. Roles of different T-cell subsets in control of herpes simplex virus infection determined by using T-cell-deficient mouse-models. J. Virol. 69: 8178-8179.
9. Simmons, A., and D. C. Tscharke. 1992. Anti-CD8 impairs clearance of herpes simplex virus from the nervous system: implications for the fate of virally infected neurons. J. Exp. Med. 175: 1337-1344.
10. + T cells are involved in protection against HSV-1 induced corneal scarring. Br. J. Ophthalmol. 84: 408-412.
11. Zlotnik, A., and O. Yoshie. 2000. Chemokines: a new classification system and their role in immunity. Immunity 12: 121-127. (Pubitemid 30398626)
12. Baggiolini, M. 1998. Chemokines and leukocyte traffic. Nature 392: 565-568.
13. Ward, S. G., K. Bacon, and J. Westwick. 1998. Chemokines and T lymphocytes: more than an attraction. Immunity 9: 1-11.
14. Carr, D. J., and L. Tomanek. 2006. Herpes simplex virus and the chemokines that mediate the inflammation. Curr. Top. Microbiol. Immunol. 303: 47-65.
15. Allan, R., J. Waithman, S. Bedoui, C. Jones, J. Villadangos, Y. Zhan, A. Lew, K. Shortman, W. Heath, and F. Carbone. 2006. Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming. Immunity 25: 153-162. (Pubitemid 44066832)
16. Khanna, K., A. Lepisto, V. Decman, and R. Hendricks. 2004. Immune control of herpes simplex virus during latency. Curr. Opin. Immunol. 16: 463-469. (Pubitemid 38881674)
17. Wickham, S., B. Lu, J. Ash, and D. J. Carr. 2005. Chemokine receptor deficiency is associated with increased chemokine expression in the peripheral and central nervous systems and increased resistance to herpetic encephalitis. J. Neuroimmunol. 162: 51-59. (Pubitemid 40503098)
18. + T cells. Blood 110: 2215-2216.
19. Cook, W., M. Kramer, R. Walker, T. Burwell, H. Holman, D. Coen, and D. Knipe. 2004. Persistent expression of chemokine and chemokine receptor RNAs at primary and latent sites of herpes simplex virus 1 infection. Virol. J. 1: 5. (Pubitemid 40412663)
20. O'Garra, A., L. McEvoy, and A. Zlotnik. 1998. T-cell subsets: chemokine receptors guide the way. Curr. Biol. 8: R646-R649. (Pubitemid 28448066)
21. Hsieh, M. F., S. L. Lai, J. P. Chen, J. M. Sung, Y. L. Lin, B. A. Wu-Hsieh, C. Gerard, A. D. Luster, and F. Liao. 2006. Both CXCR3 and CXCL10/IFN-inducible protein 10 are required for resistance to primary infection by dengue virus. J. Immunol. 77: 1855-1863.
22. + effector T cells involved in immune surveillance of the lymphocytic choriomeningitis virus infected central nervous system. J. Immunol. 176: 4235-4243.
23. + T-cell recruitment and control of West Nile virus encephalitis. J. Virol. 79: 11457-11466.
24. Trifilo, M. J., C. Montalto-Morrison, L. N. Stiles, K. R. Hurst, J. L. Hardison, J. E. Manning, P. S. Masters, and T. E. Lane. 2004. CXC chemokine ligand 10 controls viral infection in the central nervous system: evidence for a role in innate immune response through recruitment and activation of natural killer cells. J. Virol. 78: 585-594.
25. + T cell trafficking following viral infection of the CNS. Eur. J. Immunol. 36: 613-622.
26. Carr, D. J., T. Wuest, and J. J. Ash. 2008. An increase in herpes simplex virus type 1 in the anterior segment of the eye is linked to a deficiency in NK cell infiltration in mice deficient in CXCR3. J. Interferon Cytokine Res. 28: 245-251.
27. Zhang, B., Y. K. Chan, B. Lu, M. S. Diamond, and R. S. Klein. 2008. CXCR3 mediates region-specific antiviral T cell trafficking within the central nervous system during West Nile virus encephalitis. J. Immunol. 180: 2641-2649.
28. Dufour, J. H., M. Dziejman, M. T. Liu, J. H. Leung, T. E. Lane, and A. D. Luster. 2002. IFN-γ-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J. Immunol. 168: 3195-3204.
29. Hancock, W. W., B. Lu, W. Gao, V. Csizmadia, K. Faia, J. A. King, S. T. Smiley, M. Ling, N. P. Gerard, and C. Gerard. 2000. Requirement of the chemokine receptor CXCR3 for acute allograft rejection. J. Exp. Med. 192: 1515-1520.
30. Park, M. K., D. Amichay, P. Love, E. Wick, F. Liao, A. Grinberg, R. L. Rabin, H. H. Zhang, S. Gebeyehu, T. M. Wright, et al. 2002. The CXC chemokine murine monokine induced by IFN-γ (CXC chemokine ligand 9) is made by APCs, targets lymphocytes including activated B cells, and supports antibody responses to a bacterial pathogen in vivo. J. Immunol. 169: 1433-1439.
31. Saudemont, A., N. Jouy, D. Hetuin, and B. Quesnel. 2005. NK cells that are activated by CXCL10 can kill dormant tumor cells that resist CTL-mediated lysis and can express B7-H1 that stimulates T cells. Blood 105: 2428-2435. (Pubitemid 40387042)
32. Austin, B. A., and D. J. Carr. 2007. Herpes simplex virus type 1 suppresses type I interferon-induced chemokine production in trigeminal ganglion cell cultures. In Chemokine Research Trends. L. Grinwald, ed. Nova Science Publishers, Hauppauge, NY, pp. 43-60.
33. Carr, D. J., and I. L. Campbell. 2006. Herpes simplex virus type 1 induction of chemokine production is unrelated to viral load in the cornea but not in the nervous system. Viral Immunol. 19: 741-746.
34. Whiting, D., G. Hsieh, J. J. Yun, A. Banerji, W. Yao, M. Fishbein, J. Belperio, R. Strieter, B. Bonavida, and A. Ardehali. 2004. Chemokine monokine induced by IFN-γ/CXC chemokine ligand 9 stimulates T lymphocyte proliferation and effector cytokine production. J. Immunol. 172: 7417-7424. (Pubitemid 38747603)
35. Hanke, T., F. L. Graham, K. L. Rosenthal, and D. C. Johnson. 1991. Identification of an immunodominant cytotoxic T-lymphocyte recognition site in glycoprotein B of herpes simplex virus by using recombinant adenovirus vectors and synthetic peptides. J. Virol. 65: 1177-11786.
36. Cose, S. C., J. M. Kelly, and F. R. Carbone. 1995. Characterization of diverse primary herpes simplex virus type 1 gB-specific cytotoxic T-cell response showing a preferential Vβ bias. J. Virol. 69: 5849-5852.
37. Poast, J., H. M. Seidel, M. D. Hendricks, J. A. Haslam, H. B. Levy, and S. Baron. 2002. PolyI:C induction of the interferon system in mice: an initial study of four detection methods. J. Interferon Cytokine Res. 22: 1035-1040. (Pubitemid 35379015)
38. Ronnblom, L., U. Ramstedt, and G. V. Alm. 1983. Properties of human natural interferon-producing cells stimulated by tumor cell lines. Eur. J. Immunol. 13: 471-476.
39. Perussia, B., V. Fanning, and G. Trinchieri. 1985. A leukocyte subset bearing HLA- DR antigens is responsible for in vitro α interferon production in response to viruses. Nat. Immun. Cell Growth Regul. 4: 120-137. (Pubitemid 15228688)
40. Siegal, F., N. Kadowaki, M. Shodell, P. A. Fitzgerald-Bocarsly, K. Shah, S. Ho, S. Antonenko, and Y. J. Liu. 1999. The nature of the principal type 1 interferon-producing cells in human blood. Science 284: 1835-1837. (Pubitemid 29275623)
41. Fitzgerald-Bocarsly, P., J. Dai, and S. Singh. 2008. Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history. Cytokine Growth Factor Rev. 19: 3-19.
42. Noisakran, S., and D. J. Carr. 2001. Type I interferons and herpes simplex virus infection: a naked DNA approach as a therapeutic option? Immunol. Res. 24: 1-11. (Pubitemid 32612582)
43. Jouanguya, E., S. Zhanga, A. Chapgiera, V. Sancho-Shimizua, A. Puela, C. Picarda, S. Boisson-Dupuisa, L. Abela, and J. L. Casanova. 2007. Human primary immunodeficiencies of type I interferons. Biochimie 8: 878-883.
44. Yoneyama, H., K. Matsuno, Y. Zhang, T. Nishiwaki, M. Kitabatake, S. Ueha, S. Narumi, S. Morikawa, T. Ezaki, B. Lu, et al. 2004. Evidence for recruitment of plasmacytoid dendritic cell precursors to inflamed lymph nodes through high endothelial venules. Int. Immunol. 16: 915-928. (Pubitemid 38967174)
45. Yoneyama, H., K. Matsuno, E. Toda, T. Nishiwaki, N. Matsuo, A. Nakano, S. Narumi, B. Lu, C. Gerard, S. Ishikawa, and K. Matsushima. 2005. Plasmacytoid DCs help lymph node DCs to induce anti-HSV CTLs. J. Exp. Med. 202: 425-435. (Pubitemid 41126960)
46. Yoneyama, H., S. Narumi, Y. Zhang, M. Murai, M. Baggiolini, A. Lanzavecchia, T. Ichida, H. Asakura, and K. Matsushima. 2002. Pivotal role of dendritic cell-derived CXCL10 in the retention of T helper cell 1 lymphocytes in secondary lymph nodes. J. Exp. Med. 195: 1257-1266. (Pubitemid 34564328)
47. Dar, W. A., and S. J. Knechtle. 2007. CXCR3-mediated T-cell chemotaxis involves ZAP-70 and is regulated by signalling through the T-cell receptor. Immunology 120: 467-485.
48. Burns, J. M., B. C. Summers, Y. Wang, A. Melikian, R. Berahovich, Z. Miao, M. E. Penfold, M. J. Sunshine, D. R. Littman, C. J. Kuo, et al. 2006. A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J. Exp. Med. 203: 2201-2213.
49. Thapa, M., R. Welner, R. Pelayo, and D. J. Carr. 2008. CXCL9 and CXCL10 expression are critical for control of genital herpes simplex virus type 2 infection through mobilization of HSV-specific CTL and NK cells to the nervous system. J. Immunol. 180: 1098-1106.
50. Wuest, T., and D. J. Carr. 2008. The role of chemokines during herpes simplex virus-1 infection. Front. Biosci. 13: 4862-4872. (Pubitemid 351599641)
51. Hess, C., T. Means, P. Autissier, T. Woodberry, M. Altfeld, M. Addo, N. Frahm, C. Brander, B. Walker, and A. D. Luster. 2004. IL-8 responsiveness defines a subset of CD8 T cells poised to kill. Blood 104: 3463-3471. (Pubitemid 39564414)
52. Soejima, K., and B. J. Rollins. 2001. A functional IFN-γ-inducible protein- 10/CXCL10-specific receptor expressed by epithelial and endothelial cells that is neither CXCR3 nor glycosaminoglycan. J. Immunol. 167: 6576-6582. (Pubitemid 33081594)
53. Loetscher, P., A. Pellegrino, J. H. Gong, I. Mattioli, M. Loetscher, G. Bardi, M. Baggiolini, and I. Clark-Lewis. 2001. The ligands of CXC chemokine receptor 3, I-TAC, Mig, and IP10, are natural antagonists for CCR3. J. Biol. Chem. 276: 2986-2991. (Pubitemid 37411585)
54. Inngjerdingen, M., B. Rolstad, and J. C. Ryan. 2003. Activating and inhibitory Ly49 receptors modulate NK cell chemotaxis to CXC chemokine ligand (CXCL) 10 and CXCL12. J. Immunol. 171: 2889-2895. (Pubitemid 37093509)
55. Vanbervliet, B., N. Bendriss-Vermare, C. Massacrier, B. Homey, O. de Bouteiller, G. Brière, F. Trinchieri, and C. Caux. 2003. The inducible CXCR3 ligands control plasmacytoid dendritic cell responsiveness to the constitutive chemokine stromal cell-derived factor 1 (SDF-1)/CXCL12. J. Exp. Med. 198: 823-830.
56. Kumar, A., T. D. Humphreys, K. N. Kremer, P. S. Bramati, L. Bradfield, C. E. Edgar, and K. E. Hedin. 2006. CXCR4 physically associates with the T cell receptor to signal in T cells. Immunity 25: 213-224. (Pubitemid 44224150)
57. Campanella, G. S., J. Grimm, L. A. Manice, R. A. Colvin, B. D. Medoff, G. R. Wojtkiewicz, R. Weissleder, and A. D. Luster. 2006. Oligomerization of CXCL10 is necessary for endothelial cell presentation and in vivo activity. J. Immunol. 177: 6991-6998.
58. Tharp, W. G., R. Yadav, D. Irimia, A. Upadhyaya, A. Samadani, O. Hurtado, S. Y. Liu, S. Munisamy, D. M. Brainard, M. J. Mahon, et al. 2006. Neutrophil chemorepulsion in defined interleukin-8 gradients in vitro and in vivo. J. Leukocyte Biol. 79: 539-554.
59. Poznansky, M. C., I. T. Olszak, R. Foxall, R. H. Evans, A. D. Luster, and D. T. Scadden. 2000. Active movement of T cells away from a chemokine. Nat. Med. 6: 543-548.
60. Weng, Y., S. J. Siciliano, K. E. Waldburger, A. Sirotina-Meisher, M. J. Staruch, B. L. Daugherty, S. L. Gould, M. S. Springer, and J. A. DeMartino. 1998. Binding and functional properties of recombinant and endogenous CXCR3 chemokine receptors. J. Biol. Chem. 273: 18288-18291. (Pubitemid 28334752)
61. Cox, M. A., C. H. Jenh, W. Gonsiorek, J. Fine, S. Narula, P. Zavodny, and R. Ripkin. 2001. Human interferon-inducible 10-kDa protein and human interferon-inducible T cell α chemoattractant are allotopic ligands for human CXCR3: differential binding to receptor states. Mol. Pharmacol. 59: 707-715.
62. Dagan-Berger, M., R. Feniger-Barish, S. Avniel, H. Wald, E. Galun, V. Grabovsky, R. Alon, A. Nagler, A. Ben-Baruch, and A. Peled. 2006. Role of CXCR3 carboxyl terminus and third intracellular loop in receptor-mediated migration, adhesion and internalization in response to CXCL11. Blood 107: 3821-3831.
63. Colvin, R. A., G. S. Campanella, J. Sun, and A. D. Luster. 2004. Intracellular domains of CXCR3 that mediate CXCL9, CXCL10, and CXCL11 function. J. Biol. Chem. 279: 30219-30227.
64. Booth, V., D. W. Keizer, M. B. Kamphuis, I. Clark-Lewis, and B. D. Sykes. 2002. The CXCR3 binding chemokine IP-10/CXCL10: structure and receptor interactions. Biochemistry 41: 10418-10425. (Pubitemid 34898398)
65. Booth, V., I. Clark-Lewis, and B. D. Sykes. 2004. NMR structure of CXCR3 binding chemokine CXCL11 (ITAC). Protein Sci. 13: 2022-2028. (Pubitemid 38989609)
66. Xanthou, G., T. J. Williams, and J. E. Pease. 2003. Molecular characterization of the chemokine receptor CXCR3: evidence for the involvement of distinct extracellular domains in a multi-step model of ligand binding and receptor activation. Eur. J. Immunol. 33: 2927-2936. (Pubitemid 37337159)
67. Liao, F., R. L. Rabin, J. R. Yannelli, L. G. Koniaris, P. Vanguri, and J. M. Farber. 1995. Human Mig chemokine: biochemical and functional characterization. J. Exp. Med. 182: 1301-1314.
68. Van den Steen, P. E., S. J. Husson, P. Proost, J. Van Damme, and G. Opdenakker. 2005. Carboxyterminal cleavage of the chemokines MIG and IP-10 by gelatinase B and neutrophil collagenase. Biochem. Biophys. Res. Commun. 310: 889-896.